Clinical Trial Update: Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of ALT-836 (anti-TF antibody) in septic patients with acute lung injury or acute respiratory distress syndrome; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome
• Sepsis

Drugs mentioned

• ALT-836 (anti-tissue factor antibody)

Snippet

Sponsor: Altor BioScience | Conditions: Sepsis, Acute Lung Injury | Phase 2 | Status: COMPLETED